Key Events This Week
Jan 27: Stock rises 1.98% to Rs.317.45 amid positive market sentiment
Jan 29: Golden Cross formation signals potential bullish breakout
Jan 30: MarketsMOJO upgrades rating to Hold; stock rebounds 3.92% to Rs.322.30
Feb 03
BSE+NSE Vol: 30.17 k
The next results date for Fermenta Biotech Ltd is scheduled for 09 February 2026....
Read full news article
Jan 27: Stock rises 1.98% to Rs.317.45 amid positive market sentiment
Jan 29: Golden Cross formation signals potential bullish breakout
Jan 30: MarketsMOJO upgrades rating to Hold; stock rebounds 3.92% to Rs.322.30

Fermenta Biotech Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, robust quarterly financial performance, and attractive valuation metrics. Despite recent price weakness, the company’s fundamentals and technical outlook have shifted positively, prompting a reassessment of its market stance.
Read full news article
Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite recent price declines. The company’s technical indicators present a complex picture, with weekly signals generally positive while monthly metrics remain cautious. This nuanced outlook comes amid a broader market environment where Fermenta’s performance continues to lag the Sensex over short and medium terms, though it boasts impressive long-term returns.
Read full news article
Recent Price Movement and Market Context
Fermenta Biotech’s stock has underperformed relative to the broader market and its sector peers over multiple time frames. In the past week, the stock declined by 4.08%, while the Sensex gained 0.31%. Over the last month, the stock’s fall of 11.51% significantly outpaced the Sensex’s modest 2.51% decline. Year-to-date, the stock is down 10.43%, compared to a 3.11% drop in the benchmark index. The one-year performance is particularly stark, with Fermenta Biotech’s shares falling 14.63% even as the Sensex rose by 7.88%. These figures highlight a persistent weakness in the stock despite broader market gains.
On the day of the decline, the stock reversed a two-day rally, hitting an intraday low of ₹305.25, representing a 5.58% drop ...
Read full news article
Fermenta Biotech Ltd has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) crosses above the 200-DMA. This development often signals a potential bullish breakout and a shift in long-term momentum, suggesting that investors may want to reassess the stock’s outlook amid evolving market dynamics.
Read full news article
Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Fermenta Biotech Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite some bullish cues on weekly charts, monthly indicators and moving averages suggest caution for investors as the stock navigates a challenging phase within the Pharmaceuticals & Biotechnology sector.
Read full news article
Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a recent upgrade in price, the stock’s overall technical grade has been downgraded to Sell, signalling caution for investors amid mixed market dynamics.
Read full news articleFermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve unaudited financial results (standalone and consolidated) for quarter and nine months ended December 31 2025.
Certificate under Reg. 74(5) for the quarter ended December 31 2025.
Intimation of order received from Central Goods & Services Tax - Mandi Division
09 Feb 2026
Fermenta Biotech Ltd has declared 50% dividend, ex-date: 06 Aug 25
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available